Evaluating Effect of the Study Drug Praluent (Alirocumab) on Neurocognitive Function When Compared to Placebo
Clinical trial NCT02957682 · COMPLETED
Trial details
- NCT number
- NCT02957682
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-02
- Primary completion
- 2020-03-05
- Enrollment
- 2176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.